[go: up one dir, main page]

NO20064085L - Diettsupplement med stokiometrisk spesifikt kaliummagnesiumcitrate - Google Patents

Diettsupplement med stokiometrisk spesifikt kaliummagnesiumcitrate

Info

Publication number
NO20064085L
NO20064085L NO20064085A NO20064085A NO20064085L NO 20064085 L NO20064085 L NO 20064085L NO 20064085 A NO20064085 A NO 20064085A NO 20064085 A NO20064085 A NO 20064085A NO 20064085 L NO20064085 L NO 20064085L
Authority
NO
Norway
Prior art keywords
dietary supplement
magnesium citrate
potassium magnesium
specific potassium
stoichiometric
Prior art date
Application number
NO20064085A
Other languages
English (en)
Inventor
Dennis S Rushforth
Original Assignee
Mission Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34912611&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20064085(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mission Pharma Co filed Critical Mission Pharma Co
Publication of NO20064085L publication Critical patent/NO20064085L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det beskrives en spesifikk form av et dualmineralsalt med kalium, magnesium og citrat i et støkiometrisk forhold for kalium:magnesium på mindre enn 4:1. Det beskrives fremgangsmåter for fremstilling av preparatet og bruk av dette som diettsupplement
NO20064085A 2004-03-08 2006-09-13 Diettsupplement med stokiometrisk spesifikt kaliummagnesiumcitrate NO20064085L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/797,321 US7091246B2 (en) 2004-03-08 2004-03-08 Dietary supplementation with stoichiometrically specific potassium magnesium citrate
PCT/US2005/007571 WO2005087218A1 (en) 2004-03-08 2005-03-08 Dietary supplementation with stoichiometrically specific potassium magnesium citrate

Publications (1)

Publication Number Publication Date
NO20064085L true NO20064085L (no) 2006-12-07

Family

ID=34912611

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064085A NO20064085L (no) 2004-03-08 2006-09-13 Diettsupplement med stokiometrisk spesifikt kaliummagnesiumcitrate

Country Status (10)

Country Link
US (1) US7091246B2 (no)
EP (1) EP1722772A4 (no)
AR (1) AR048167A1 (no)
AU (1) AU2005221662B2 (no)
MX (1) MXPA06010133A (no)
MY (1) MY136877A (no)
NO (1) NO20064085L (no)
PE (1) PE20061101A1 (no)
TW (1) TWI282274B (no)
WO (1) WO2005087218A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10251909B2 (en) * 2007-02-09 2019-04-09 Board Of Regents, The University Of Texas System Potassium-magnesium citrate as a surrogate of the DASH diet in managing hypertension
IL191876A (en) * 2008-06-02 2013-12-31 Gadot Biochemical Ind Ltd Potassium magnesium citrate, a process for its preparation and use
EP2389078A4 (en) * 2009-01-22 2012-10-31 Mission Pharma Co DOUBLE CATION AND DOUBLE ANION COORDINATION COMPLEXES
DE102010053748B4 (de) * 2010-12-08 2023-08-03 Jörg Schierholz Pharmazeutische Zusammensetzung zur Behandlung von Übergewicht
US10285961B2 (en) 2014-02-06 2019-05-14 University Of Houston System Organic acids as agents to dissolve calcium minerals in pathological calcification and uses thereof
SI3349594T1 (sl) * 2015-09-14 2020-07-31 Podravka D.D. Sestavek nadomestka soli in uporaba le-tega
CN110398514B (zh) * 2018-04-24 2023-04-28 恒天纤维集团有限公司 一种快速判断纤维素胶液中金属杂质含量的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE968843C (de) * 1953-11-29 1958-04-03 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von pharmakologisch wirksamen Magnesiumsalzen der Citronensaeure
US4985593A (en) 1988-01-05 1991-01-15 Mission Pharmacal Company, Inc. Magnesium potassium citrate
US5219889A (en) 1988-01-05 1993-06-15 The University Of Texas System Dietary supplementation with potassium magnesium citrate
US4895980A (en) 1988-01-05 1990-01-23 Mission Pharmacal Company, Inc. Method of manufacturing magnesium potassium citrate
CA1326040C (en) * 1989-11-16 1994-01-11 Neill B. Walsdorf Magnesium-potassium citrate
US6514537B1 (en) 2000-06-02 2003-02-04 Cumberland Swan Holdings, Inc. Magnesium citrate solution
CN1486969A (zh) * 2003-08-13 2004-04-07 南京市鼓楼医院 枸橼酸氢钾镁复合矿物盐及制备方法

Also Published As

Publication number Publication date
TWI282274B (en) 2007-06-11
PE20061101A1 (es) 2007-01-03
TW200531681A (en) 2005-10-01
EP1722772A4 (en) 2008-03-19
EP1722772A1 (en) 2006-11-22
US20050197402A1 (en) 2005-09-08
US7091246B2 (en) 2006-08-15
WO2005087218A1 (en) 2005-09-22
MXPA06010133A (es) 2007-03-21
AU2005221662A1 (en) 2005-09-22
AR048167A1 (es) 2006-04-05
AU2005221662B2 (en) 2008-04-17
MY136877A (en) 2008-11-28

Similar Documents

Publication Publication Date Title
NO20075009L (no) Ernaeringstilsetning for HIV-pasienter
UA94221C2 (en) Lipocalin protein
NO20082144L (no) Blanding av jern- og kobbersalter som maskerer metallisk smak
WO2008128049A3 (en) Tetrahydrobiopterin compositions and methods of measuring
MX2007008021A (es) Composiciones que incluyen hierro.
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
NO20091509L (no) Substituerte tetrahydropyrrolopyrazinforbindelser med affinitet KCNQ2/3 K+ kanal og anvendelse derav i medikamenter
WO2007123995A3 (en) Camptothecin-analog with a novel, “flipped” lactone-stable, e-ring and methods for making and using same
WO2009110780A3 (es) Composiciones con bajo contenido de sal de sodio y métodos de preparación y usos de éstas
ZA200704430B (en) Syntheis and uses of 2-oxo-4-methylthiobutyric acid, its salts and its derivatives
WO2004017998A3 (en) Topical emulsion- gel composition comprising diclofenac sodium
MY148723A (en) Use of pinolenic acid for the treatment of obesity
CA120236S (en) Detachable bootie with garment
NO20064085L (no) Diettsupplement med stokiometrisk spesifikt kaliummagnesiumcitrate
TW200602076A (en) O, O'-amidomalonate and N, O-amidomalonate platinum complexes
MA33022B1 (fr) Composition à libération contrôlée pour produire une préparation à libération prolongée contenant de l'udénafil
TW200633696A (en) Sesamin/episesamin compositions
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
GT200500266A (es) Nuevos derivados de pirimidina y su uso
DK1753309T3 (da) Fødevaresammensætninger indeholdende kreatin
HRP20090513T1 (hr) S-mirtazapin, namijenjen liječenju napadaja vrućine
CA118372S (en) Trapeze hanger
MX2007002917A (es) Todo-trans-retinol: todo-trans-13, 14-dihidrorretinol saturasa y metodos de uso de la misma.
MY146444A (en) Benzooxazol-2-one derivatives as inhibitors of lipases and phospholipases
ITMI20051446A1 (it) Composizione per ridurre i lipid nel sangue

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application